Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridines

Journal of Medicinal Chemistry

Volumn 46, Issue 6, 2003, Pages 1049-1054

  Deady, Leslie W ^a   Rodemann, Thomas ^a   Zhuang, Li ^b   Baguley, Bruce C ^b   Denny, William A ^b  

^a LA TROBE UNIVERSITY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

1 OXO 1,2 DIHYDROBENZO[B][1,6]NAPHTHYRIDINE 4 CARBOXYLIC ACID DERIVATIVE; 2 (3,4 DIMETHOXYPHENYL) 6 METHYL 1 OXO 1,2 DIHYDROBENZO[B][1,6]NAPHTHYRIDINE 4 CARBOXYLIC ACID; 2 METHYL 1 OXO 1,2 DIHYDROBENZO[B][1,6]NAPHTHYRIDINE 4 CARBOXYLIC ACID; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL REACTION; COLON TUMOR; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL LINE; LEUKEMIA P 388; LEWIS CARCINOMA; MOUSE; NONHUMAN; STRUCTURE ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; NAPHTHYRIDINES; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0037435068     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020420u     Document Type: Article

References (23)

1. Asbury, R.; Blessing, J. A.; Reid, G. C.; McGuire, W. P. A phase II trial of amonafide in patients with endometrial cancer-a gynecologic oncology group study. Am. J. Clin. Oncol. 1998, 21, 406-407.
2. Leaf, A. N.; Neuberg, D.; Schwartz, E. L.; Wadler, S.; Ritch, P. S.; Dutcher, J. P.; Adams, G. L. An ecog phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Invest. New Drugs 1997, 15, 165-172.
3. Koller, C. A.; Kantarjian, H. M.; Feldman, E. J.; O'Brien, S.; Rios, M. B.; Estey, E.; Keating, M. A. Phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia. Cancer 1999, 86, 2246-2251.
4. Atwell, G. J.; Rewcastle, G. W.; Baguley, B. C.; Denny, W. A. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. J. Med. Chem. 1987, 30, 664-669.
5. Baguley, B. C.; Zhuang, L.; Marshall, E. M. Experimental solid tumour activity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. Cancer Chemother. Pharmacol. 1995, 36, 244-248.,
6. Deady, L. W.; Rodemann, T. The reaction of homophthalic acid and some aza analogues with Vilsmeier reagent; a reinvestigation. J. Heterocycl. Chem. 2001, 38, 1185-1190.
7. Asherson, J. L.; Young, D. W. Synthesis of a variety of polycyclic heteroaromatic compounds via quinone methide intermediates. J. Chem. Soc., Chem. Commun. 1977, 916-917.
8. Khattab, A. F. Ring closure of 4-azido-3-formyl (or acetyl-)2-pyridones to isoxazolo[4,3,c]pyridones. Liebigs Ann. 1996, 393-395.
9. Meth-Cohn, O. A versatile synthesis of quinolines and related fused pyridines. 13. Vilsmeier cyclizations in which the reagent nitrogen is incorporated into the product: the action of N-formyl derivatives of cyclic amines with 2-alkylarylcarboxylic acids. S. Afr. J. Chem. 1987, 40, 189-190.
10. Rivalle, C.; Bisagni, E. Nouvelle synthèse des pyrido[4,3-b]-quinoléines substituées sur leur sommet 1 (New synthesis of pyrido[4,3-b]quinolines substituted at position 1). J. Heterocycl. Chem. 1980, 17, 245-248.
11. Vijayalakshmi, S.; Rajendran, S. P. Synthesis of dibenzo[b,h]-[1,6] naphthyridin-6(5H)-ones. Indian J. Chem. 1994, 33B, 159-162.
12. Gabriel, S. Synthesis of derivatives of isoquinolines. Ber. Dtsch. Chem. Ges. 1885, 18, 3470-3480.
13. Jhalani, V. K.; Ghalsasi, L. P.; Acharya, S. P.; Usgaonkar, R. N. Synthesis of 1,6-naphthyridin-5(6H)-ones from 8-substituted 7-methylpyrano[4,3-b]pyridine. Indian J. Chem. 1989, 28B, 173-174.
14. Modi, A. R.; Usgaonkar, R. N. Isoquinolones: Part IV-Synthesis of 3-methyl, 3-formyl and other 3-substituted N-arylisoquinolones. Indian J. Chem. 1979, 18B, 304-306.
15. Finlay, G. J.; Baguley, B. C.; Snow, K.; Judd, W. Multiple patterns of resistance of human leukemia cell sublines to amsacrine analogs. J. Natl. Cancer Inst. 1990, 82, 662-667.
16. Finlay, G. J.; Holdaway, K. M.; Baguley, B. C. Comparison of the effects of genistein and amsacrine on leukemia cell proliferation. Oncol. Res. 1994, 6, 33-37.
17. Bu, X.; Deady, L. W.; Finlay, G. J.; Baguley, B. C.; Denny, W. A. Synthesis and cytotoxic activity of 7-oxo-7H-dibenz[f,ij]-isoquinoline and 7-oxo-7H-benzo[e]perimidine derivatives. J. Med. Chem. 2001, 44, 2004-2014.
18. Spicer, J. A.; Gamage, S. A.; Atwell, G. J.; Finlay, G. J.; Baguley, B. C.; Denny, W. A. Structure activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. J. Med. Chem. 1997, 40, 1919-1929.
19. Deady, L. W.; Desneves, J.; Kaye, A. J.; Finlay, G. J.; Baguley, B. C.; Denny, W. A. Synthesis and antitumor activity of some indeno[1,2-b]quinoline-based bis carboxamides. Bioorg. Med. Chem. 2000, 8, 977-984 and references therein.
20. Antonini, I.; Polucci, P.; Kelland, L. R.; Spinelli, S.; Pescalli, N.; Martelli, S. N4-(wAminoalkyl)-1-[(w-aminoalkyl)amino]-4-acridinecarboxamides: Novel, potent, cytotoxic, and DNA-binding agents. J. Med. Chem. 2000, 43, 4801-4805.
21. Finlay, G. J.; Riou, J.-F.; Baguley, B. C. From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivatives. Eur. J. Cancer 1996, 32A, 708-714.
22. Marshall, E. S.; Finlay, G. J.; Matthews, J. H. L.; Shaw, J. H. F.; Nixon, J.; Baguley, B. C. Microculture-based chemosensitivity testing: a feasibility study comparing freshly explanted melanoma cells with human melanoma cell lines. J. Natl. Cancer Inst. 1992, 84, 340-345.
23. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.